7:47 am Cardiome Pharma’s BRINAVESS demonstrates 74% cardioversion in post-cardiac surgery patients with atrial fibrillation
View todays social media effects on CRME
View the latest stocks trending across Twitter. Click to view dashboard
See who Cardiome is hiring next, click here to view
